Based on the provided data and recent market developments, I'll analyze whether FSK is overvalued.
Valuation Analysis
FSK currently trades at compelling valuation metrics with a P/E of 10.46x, P/B of 0.83x, and EV/EBITDA of 12.96x as of Q3 2024 . The stock trades at approximately 13% discount to its NAV of $23.82, suggesting it remains undervalued relative to its intrinsic value.
Portfolio Quality
FSK's portfolio quality has significantly improved with non-accruals at only 1.7% on fair value basis, which is below industry average and shows a 10 basis point improvement from previous quarter. The majority (88%) of FSK's portfolio maintains extremely low non-accruals of just 0.5%.
Income Generation
The company maintains a healthy dividend coverage ratio of 106% based on Q3 2024 adjusted NII of $0.74 per share versus $0.70 quarterly dividend. While there may be some pressure on NII due to interest rate cuts, the base dividend of $0.64 quarterly remains well-covered with a 115% coverage ratio.
Market Position & Growth
FSK demonstrated strong origination activity with over $1.1 billion in new investments in Q3 2024, resulting in net portfolio growth of $185 million. The company maintains conservative leverage at 1.09x, below sector average of 1.16x, providing additional growth capacity.
Conclusion
FSK is not overvalued based on multiple metrics: significant NAV discount, improving portfolio quality, strong dividend coverage, and conservative leverage profile. The current valuation appears attractive given the company's fundamental strengths and market position.